Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitral valve replacement using a cryopreserved mitral homograft

C Acar1, A Farge, A Ramsheyi

  • 1Department of Cardiovascular Surgery, Hôpital Broussais, Paris, France.

The Annals of Thoracic Surgery
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early onset radiation-induced leukoencephalopathy in patients treated for a glioblastoma by STUPP protocol and risk factors evaluation, an ancillary study of the phase III ASTER protocol.

Revue neurologique·2026
Same author

CAR T-cell-associated neurotoxicity: A comprehensive review.

Revue neurologique·2024
Same author

Author Correction: Cardiovascular, hematological and neurosensory impact of COVID-19 and variants.

European review for medical and pharmacological sciences·2021
Same author

Hypometabolism on brain FDG-PET as a marker for neurotoxicity after CAR T-cell therapy: A case report.

Revue neurologique·2021
Same author

Cardiovascular, hematological and neurosensory impact of COVID-19 and variants.

European review for medical and pharmacological sciences·2021
Same author

Predictive factors of human cytomegalovirus reactivation in newly diagnosed glioblastoma patients treated with chemoradiotherapy.

Journal of neurovirology·2021

Mitral valve replacement using a cryopreserved mitral homograft was successful in a patient with calcified mitral stenosis. Echocardiography confirmed normal homograft function six months post-surgery.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Transplantation
  • Valvular Heart Disease

Background:

  • Calcified mitral stenosis presents a significant challenge in cardiac surgery.
  • Mitral valve replacement is a common treatment for severe mitral stenosis.
  • Homograft valves offer a biological alternative for valve replacement.

Observation:

  • A 49-year-old patient with calcified mitral stenosis underwent mitral valve replacement.
  • A cryopreserved mitral homograft was utilized for the valve replacement procedure.
  • The patient experienced an uneventful postoperative recovery.

Findings:

  • Transesophageal echocardiography was performed six months after the surgery.
  • The mitral homograft demonstrated normal function.

Related Experiment Videos

  • No complications or adverse events related to the homograft were noted.

    • Implications:

    • Cryopreserved mitral homografts are a viable option for mitral valve replacement in select patients.
    • Successful homograft function indicates a potentially durable solution for mitral stenosis.
    • This case highlights the safety and efficacy of homograft use in mitral valve surgery.